K Number
K080905
Device Name
QUANTUM/ CANON CXDI INTEGRATION SYSTEM, MODEL QG-DIG-CXDI
Date Cleared
2008-07-16

(106 days)

Product Code
Regulation Number
892.2050
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Quantum / Canon CXDI Integration System provides diagnostic quality images to aid the physician with diagnosis. The System can be used to perform radiographic exposures of the skeleton (including skull, spinal column and extremities), chest, abdomen and other body parts. The System is not indicated for use in mammography.
Device Description
The Quantum / Canon CXDI Integration System consists of add-on software that will allow the use of the currently marketed Quantum Q-Rad Radiographic System with the currently marketed Canon CXDI Series System, including models CXDI-40EG or CXDI-50G, as a fully integrated digital imaging system.
More Information

Not Found

No
The summary does not mention AI, ML, or any related terms, and the device description focuses on software integration of existing systems.

No
This device is for diagnostic imaging, aiding physicians with diagnosis, rather than directly treating a condition.

Yes
The "Intended Use / Indications for Use" section explicitly states that the system "provides diagnostic quality images to aid the physician with diagnosis."

No

The device is described as "add-on software" that integrates two existing hardware systems (Quantum Q-Rad Radiographic System and Canon CXDI Series System). While the device itself is software, its function is to enable the integrated operation of hardware components for image acquisition, making it part of a larger hardware-software system, not a standalone software-only medical device.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly states that the system provides "diagnostic quality images to aid the physician with diagnosis" and is used to perform "radiographic exposures" of various body parts. This describes an imaging system used for in-vivo (within the living body) diagnosis, not in-vitro (outside the living body) testing of samples like blood, urine, or tissue.
  • Device Description: The device is described as software that integrates a radiographic system with a digital imaging system. This aligns with medical imaging equipment, not IVD devices.
  • Input Imaging Modality: The input is "Radiographic exposures," which is a form of medical imaging, not a method used in IVD testing.

IVD devices are specifically designed to examine specimens derived from the human body to provide information for diagnostic, monitoring, or screening purposes. This device does not fit that description.

N/A

Intended Use / Indications for Use

The Quantum / Canon CXDI Integration System provides diagnostic quality images to aid the physician with diagnosis. The System can be used to perform radiographic exposures of the skeleton (including skull, spinal column and extremities), chest, abdomen and other body parts. The System is not indicated for use in mammography.

Product codes (comma separated list FDA assigned to the subject device)

LLZ, KPR, MQB

Device Description

The Quantum / Canon CXDI Integration System consists of add-on software that will allow the use of the currently marketed Quantum Q-Rad Radiographic System with the currently marketed Canon CXDI Series System, including models CXDI-40EG or CXDI-50G, as a fully integrated digital imaging system.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Radiographic exposures

Anatomical Site

skeleton (including skull, spinal column and extremities), chest, abdomen and other body parts

Indicated Patient Age Range

Not Found

Intended User / Care Setting

physician / Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Performance data demonstrated that the Quantum / Canon CXDI Integration System is substantially equivalent to the predicate devices and/or met pre-determined acceptance criteria. The risks associated with use of the new device were found acceptable when evaluated by standardized risk/hazard analysis techniques. Performance testing was successfully completed on the system in accordance with predetermined protocols based on the system design inputs.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K011486, K072010, K050987, K031447

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 892.2050 Medical image management and processing system.

(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).

0

Quantum Medical Imaging, LLC Quantum / Canon CXDI Integration System Traditional 510(k) Premarket Notification March 26, 2008

Section 5 - 510(k) Summary

General Information

Korogos

Owner's Name:Quantum Medical Imaging, LLCJUL 1 6 2008
Address:2002-B Orville Drive North
Ronkonkoma, NY 11779-7661
Telephone Number:(631) 567-5800
Fax Number:(631) 567-5074
Contact Person:Mark Camirand; Director Q.A./Compliance
Subject Device Name:Quantum / Canon CXDI Integration System
Common/Usual Name:Stationary Electrostatic X-Ray System
Product Codes:LLZ; KPR; MQB
Regulation:21 CFR 892.2050 / 21 CFR 892.1680 / 21 CFR 892.1650
Classification:Class II
Predicate Device Names:Quantum Q-Rad Radiographic System / Quantum DiRex System / Canon
CXDI-40EG Digital Radiography System / Canon CXDI-50G Digital
Radiography System
Manufacturers:Quantum Medical Imaging, LLC / Canon, Inc.
Premarket Notifications:K011486 / K072010 / K050987 / K031447

Device Description

The Quantum / Canon CXDI Integration System consists of add-on software that will allow the use of the currently marketed Quantum Q-Rad Radiographic System with the currently marketed Canon CXDI Series System, including models CXDI-40EG or CXDI-50G, as a fully integrated digital imaging system.

Intended Use

The Quantum / Canon CXDI Integration System provides diagnostic quality images to aid the physician with diagnosis. The System can be used to perform radiographic exposures of the skeleton (including skull, spinal column and extremities), chest, abdomen and other body parts. The System is not indicated for use in mammography.

Performance Testing

Performance data demonstrated that the Quantum / Canon CXDI Integration System is substantially equivalent to the predicate devices and/or met pre-determined acceptance criteria. The risks associated with use of the new device were found acceptable when evaluated by standardized risk/hazard analysis techniques. Performance testing was successfully completed on the system in accordance with predetermined protocols based on the system design inputs.

No biocompatibility testing was conducted in support of this 510(k); all patient-contacting materials used in the manufacture of the Quantum / Canon CXDI Integration System have been previously cleared for similar devices.

Conclusion

The Quantum / Canon CXDI Integration System meets all the pre-determined acceptance criteria of the testing performed to confirm safety and effectiveness; the System is substantially equivalent to the predicate devices.

1

Quantum Medical Imaging, LLC Quantum / Canon CXDI Integration System Traditional 510(k) Premarket Notification March 26, 2008

Section 4 - Indications for Use Statement

510(k) Number (if known):
K080905

Device Name:

Quantum / Canon CXDI Integration System

Indications for Use:

The Quantum / Canon CXDI Integration System provides diagnostic quality images to aid the physician with diagnosis. The System can be used to perform radiographic exposures of the skeleton (including skull, spinal column and extremities), chest, abdomen and other body parts. The System is not indicated for use in mammography.

Prescription Use _ X (Per 21 CFR 801 Subpart D)

מועדות במילה במילה במיני במ

OR

Over-the -Counter Use _ (Per 21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) NumberK080905

2

Section 5 - 510(k) Summary

General Information

ﻳﻨﺘﻬﺎ ﺑ

Owner's Name:Quantum Medical Imaging, LLC
Address:2002-B Orville Drive North
Ronkonkoma, NY 11779-7661
Telephone Number:(631) 567-5800
Fax Number:(631) 567-5074
Contact Person:Mark Camirand; Director Q.A./Compliance
Subject Device Name:Quantum / Canon CXDI Integration System
Common/Usual Name:Stationary Electrostatic X-Ray System
Product Codes:LLZ; KPR; MQB
Regulation:21 CFR 892.2050 / 21 CFR 892.1680 / 21 CFR 892.1650
Classification:Class II
Predicate Device Names:Quantum Q-Rad Radiographic System / Quantum DiRex System / Canon
CXDI-40EG Digital Radiography System / Canon CXDI-50G Digital
Radiography System
Manufacturers:Quantum Medical Imaging, LLC / Canon, Inc.
Premarket Notifications:K011486 / K072010 / K050987 / K031447

Device Description

The Quantum / Canon CXDI Integration System consists of add-on software that will allow the use of the currently marketed Quantum Q-Rad Radiographic System with the currently marketed Canon CXDI Series System, including models CXDI-40EG or CXDI-50G, as a fully integrated digital imaging system.

Intended Use

The Quantum / Canon CXDI Integration System provides diagnostic quality images to aid the physician with diagnosis. The System can be used to perform radiographic exposures of the skeleton (including skull, spinal column and extremities), chest, abdomen and other body parts. The System is not indicated for use in mammography.

Performance Testing

Performance data demonstrated that the Quantum / Canon CXDI Integration System is substantially equivalent to the predicate devices and/or met pre-determined acceptance criteria. The risks associated with use of the new device were found acceptable when evaluated by standardized risk hazard analysis techniques. Performance testing was successfully completed on the system in accordance with predetermined protocols based on the system design inputs.

No biocompatibility testing was conducted in support of this 510(k); all patient-contacting materials used in the manufacture of the Quantum / Canon CXDI Integration System have been previously cleared for similar devices.

Conclusion

The Quantum / Canon CXDI Integration System meets all the pre-determined acceptance criteria of the testing performed to confirm safety and effectiveness; the System is substantially equivalent to the predicate devices.

3

Image /page/3/Picture/0 description: The image shows a logo for the U.S. Department of Health and Human Services. The logo includes a stylized eagle with three lines representing its wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged around the eagle in a circular fashion. The word "DEPARTMENT" is printed in bold, sans-serif font to the right of the logo.

DEPARTMENT OF HEALTH & HUMAN SERVICES

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

JUL 1 6 2008

Ms. Pamela Papineau, RAC Consultent Quantum Medical Imaging, LLC 2002-B Orville Drive North RONKONKOMA NY 11779-7661

Re: K080905

Trade/Device Name: Quantum / Canon CXDI Integration System Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: June 3, 2008

Received: June 4, 2008

Dear Mr. Papineau:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

4

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter.

21 CFR 876.xxxx(Gastroenterology/Renal/Urology)240-276-0115
21 CFR 884.xxxx(Obstetrics/Gynecology)240-276-0115
21 CFR 892.xxxx(Radiology)240-276-0120
Other240-276-0100

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrb/industry/support/index.html.

Sincerely vours.

Nancy Bragdon

Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

5

Quantum Medical Imaging, LLC Quantum / Canon CXDI Integration System

Section 4 - Indications for Use Statement

510(k) Number (if known):

Quantum / Canon CXDI Integration System Device Name:

Indications for Use:

The Quantum / Canon CXDI Integration System provides diagnostic quality images to aid the physician with diagnosis. The System can be used to perform radiographic exposures of the skeleton (including skull, spinal column and extremities), chest, abdomen and other body parts. The System is not indicated for use in mammography.

Prescription Use __ X (Per 21 CFR 801 Subpart D)

та се двини

OR

Over-the -Counter Use _ (Per 21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

hoza m Whan

(Divisio Division of Reproductive, Abdominal and Radiological Devices 510(k) Number